Largest pharmaceuticals by earnings
Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.
Johnson & Johnson leads the 61 pharmaceuticals ranked by earnings, at NOK 260.2B, ahead of Eli Lilly (NOK 200.4B) and Merck & Co (NOK 177.2B). Figures as of 18 Nov 2026, 15:14 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- Johnson & JohnsonNOK 260.2B
- Median
- NOK 572.8M
- Combined market value
- NOK 49.66T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Earnings ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Johnson & JohnsonJNJ · Health Care | NOK 260.2B | NOK 6.46T | NOK 2,683.89 | 0.80% down | 38% up | ||
| 2 | Eli LillyLLY · Health Care | NOK 200.4B | NOK 12.11T | NOK 13,596.51 | 1.06% down | 35% up | ||
| 3 | Merck & CoMRK · Health Care | NOK 177.2B | NOK 3.37T | NOK 1,367.23 | 1.76% down | 51% up | ||
| 4 | Novo NordiskNVO · Health Care | NOK 147.6B | NOK 1.71T | NOK 389.07 | 1.53% down | 17% down | ||
| 5 | NovartisNVS · Health Care | NOK 135.8B | NOK 2.87T | NOK 1,521.49 | 1.51% down | 25% up | ||
| 6 | AstraZenecaAZN · Health Care | NOK 99.3B | NOK 2.71T | NOK 1,745.64 | 1.34% down | 2% up | ||
| 7 | SanofiSNY · Health Care | NOK 84.2B | NOK 1.11T | NOK 460.40 | 0.22% down | 4% down | ||
| 8 | PfizerPFE · Health Care | NOK 75.4B | NOK 1.57T | NOK 274.87 | 0.54% down | 14% up | ||
| 9 | GSKGSK · Health Care | NOK 73.7B | NOK 955.2B | NOK 476.55 | 0.30% down | 6% up | ||
| 10 | Bristol-Myers SquibbBMY · Health Care | NOK 68.5B | NOK 1.2T | NOK 585.71 | 1.65% down | 34% up | ||
| 11 | Abbott LaboratoriesABT · Health Care | NOK 63.3B | NOK 1.76T | NOK 1,015.33 | 0.11% down | 17% down | ||
| 12 | Regeneron PharmaceuticalsREGN · Health Care | NOK 43.7B | NOK 968.1B | NOK 9,358.27 | 0.65% up | 36% up | ||
| 13 | AbbVieABBV · Health Care | NOK 41B | NOK 4.97T | NOK 2,811.66 | 1.09% down | 26% up | ||
| 14 | Vertex PharmaceuticalsVRTX · Health Care | NOK 38.4B | NOK 1.33T | NOK 5,228.08 | 0.81% up | 27% up | ||
| 15 | ZoetisZTS · Health Care | NOK 25.9B | NOK 329.9B | NOK 811.95 | 0.19% up | 29% down | ||
| 16 | Teva Pharmaceutical IndustriesTEVA · Health Care | NOK 13.7B | NOK 481.9B | NOK 412.97 | 0.19% down | 74% up | ||
| 17 | United TherapeuticsUTHR · Health Care | NOK 13B | NOK 238.8B | NOK 5,606.68 | 1.12% down | 23% up | ||
| 18 | GenmabGMAB · Health Care | NOK 9.3B | NOK 309.6B | NOK 502.03 | 0.47% down | 70% up | ||
| 19 | Royalty PharmaRPRX · Health Care | NOK 7.5B | NOK 383.2B | NOK 666.43 | 0.04% down | 78% up | ||
| 20 | PTC TherapeuticsPTCT · Health Care | NOK 6.6B | NOK 49.2B | NOK 588.97 | 0.51% up | 20% down | ||
| 21 | Dr. Reddy's LaboratoriesRDY · Health Care | NOK 4.4B | NOK 121.4B | NOK 145.66 | 1.39% up | 5% up | ||
| 22 | TG TherapeuticsTGTX · Health Care | NOK 4.3B | NOK 93.2B | NOK 616.92 | 1.34% up | 107% up | ||
| 23 | GrifolsGRFS · Health Care | NOK 4.3B | NOK 56.7B | NOK 83.25 | 0.63% down | 1% up | ||
| 24 | BioMarin PharmaceuticalBMRN · Health Care | NOK 3.4B | NOK 112.4B | NOK 580.23 | 2.15% up | 11% up | ||
| 25 | Alnylam PharmaceuticalsALNY · Health Care | NOK 3B | NOK 201.4B | NOK 1,503.82 | 1.02% down | 66% down | ||
| 26 | BeOne MedicinesONC · Health Care | NOK 2.8B | NOK 451.2B | NOK 3,949.65 | 1.55% down | 17% up | ||
| 27 | AlkermesALKS · Health Care | NOK 2.3B | NOK 75.2B | NOK 447.38 | 1.40% up | 58% up | ||
| 28 | Ligand PharmaceuticalsLGND · Health Care | NOK 1.2B | NOK 58B | NOK 2,899.35 | 1.65% up | 43% up | ||
| 29 | Corcept TherapeuticsCORT · Health Care | NOK 967.4M | NOK 74B | NOK 676.53 | 0.54% down | 8% down | ||
| 30 | Amneal PharmaceuticalsAMRX · Health Care | NOK 699.5M | NOK 72.8B | NOK 208.81 | 1.85% up | 83% up | ||
| 31 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | NOK 572.8M | NOK 73.6B | NOK 936.89 | 1.47% up | 126% up | ||
| 32 | Arrowhead PharmaceuticalsARWR · Health Care | -NOK 15.8M | NOK 60B | NOK 424.32 | 1.67% up | 10% up | ||
| 33 | Mirum PharmaceuticalsMIRM · Health Care | -NOK 226.8M | NOK 58B | NOK 889.13 | 0.39% down | 31% up | ||
| 34 | Travere TherapeuticsTVTX · Health Care | -NOK 248M | NOK 47.1B | NOK 490.82 | 1.06% down | 44% up | ||
| 35 | VeradermicsMANE · Health Care | -NOK 679.5M | NOK 51.8B | NOK 1,227.15 | 0.61% up | 233% up | ||
| 36 | Belite BioBLTE · Health Care | -NOK 753.4M | NOK 62.5B | NOK 1,539.79 | 0.57% up | 31% up | ||
| 37 | Oruka TherapeuticsORKA · Health Care | -NOK 1B | NOK 64.4B | NOK 949.70 | 1.57% up | 241% up | ||
| 38 | ErascaERAS · Health Care | -NOK 1.2B | NOK 46B | NOK 131.01 | 2.84% down | 403% up | ||
| 39 | Protagonist TherapeuticsPTGX · Health Care | -NOK 1.3B | NOK 80.5B | NOK 1,232.59 | 1.84% up | 46% up | ||
| 40 | Spyre TherapeuticsSYRE · Health Care | -NOK 1.5B | NOK 88.4B | NOK 930.48 | 2.17% up | 286% up | ||
| 41 | Dianthus TherapeuticsDNTH · Health Care | -NOK 1.6B | NOK 47.8B | NOK 848.79 | 0.52% up | 113% up | ||
| 42 | Edgewise TherapeuticsEWTX · Health Care | -NOK 1.6B | NOK 44.3B | NOK 404.33 | 0.93% down | 88% up | ||
| 43 | Axsome TherapeuticsAXSM · Health Care | -NOK 1.8B | NOK 68.8B | NOK 1,307.14 | 0.96% down | 7% down | ||
| 44 | Definium TherapeuticsDFTX · Health Care | -NOK 1.8B | NOK 38.9B | NOK 284.34 | 0.31% down | 169% up | ||
| 45 | Rhythm PharmaceuticalsRYTM · Health Care | -NOK 1.9B | NOK 78.9B | NOK 1,138.52 | 0.57% up | 13% up | ||
| 46 | Elanco Animal HealthELAN · Health Care | -NOK 2.3B | NOK 127.8B | NOK 255.65 | 1.88% up | 20% up | ||
| 47 | Ascendis PharmaASND · Health Care | -NOK 2.5B | NOK 171.6B | NOK 2,615.79 | 0.64% down | 28% up | ||
| 48 | Madrigal PharmaceuticalsMDGL · Health Care | -NOK 2.8B | NOK 93.9B | NOK 4,042.29 | 1.32% down | 24% down | ||
| 49 | Legend BiotechLEGN · Health Care | -NOK 2.9B | NOK 30.8B | NOK 158.58 | 1.40% up | 42% down | ||
| 50 | Roivant SciencesROIV · Health Care | -NOK 2.9B | NOK 273.9B | NOK 378.02 | 0.59% up | 90% up | ||
| 51 | Praxis Precision MedicinesPRAX · Health Care | -NOK 2.9B | NOK 83.7B | NOK 2,993.18 | 1.07% up | 61% up | ||
| 52 | Cogent BiosciencesCOGT · Health Care | -NOK 3.2B | NOK 48.4B | NOK 278.22 | 2.91% up | 20% down | ||
| 53 | Jazz PharmaceuticalsJAZZ · Health Care | -NOK 3.5B | NOK 151.4B | NOK 2,359.17 | 0.96% up | 37% up | ||
| 54 | ABIVAXABVX · Health Care | -NOK 3.6B | NOK 71.4B | NOK 815.84 | 2.36% up | 27% down | ||
| 55 | Ionis PharmaceuticalsIONS · Health Care | -NOK 3.7B | NOK 43.7B | NOK 262.50 | 0.30% up | 64% down | ||
| 56 | BridgeBio PharmaBBIO · Health Care | -NOK 7.1B | NOK 146.8B | NOK 753.71 | 1.09% up | 17% up | ||
| 57 | CytokineticsCYTK · Health Care | -NOK 7.6B | NOK 70.6B | NOK 506.64 | 1.05% up | 20% down | ||
| 58 | Takeda PharmaceuticalTAK · Health Care | -NOK 9.3B | NOK 665.8B | NOK 208.38 | 0.80% down | 54% up | ||
| 59 | Summit TherapeuticsSMMT · Health Care | -NOK 10.5B | NOK 86.3B | NOK 107.95 | 4.22% up | 36% down | ||
| 60 | InsmedINSM · Health Care | -NOK 12.4B | NOK 257.8B | NOK 1,175.26 | 0.65% down | 40% down | ||
| 61 | ViatrisVTRS · Health Care | -NOK 34.1B | NOK 229.5B | NOK 200.17 | 0.83% up | 96% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Earnings is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 9.7077 NOK).
Questions and answers
Which pharmaceuticals rank first by earnings?
Johnson & Johnson (NOK 260.2B), Eli Lilly (NOK 200.4B) and Merck & Co (NOK 177.2B) are the top three of the 61 pharmaceuticals ranked by earnings as of 18 Nov 2026, 15:14 UTC.
How many pharmaceuticals are in this ranking?
61 are ranked by earnings.
What are these pharmaceuticals worth together?
The 61 pharmaceuticals ranked by earnings have a combined market value of NOK 49.66T as of 18 Nov 2026, 15:14 UTC.
What does ranking by earnings measure?
Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.
Learn how this ranking works
All markets guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
Cite this page
Funkfolio, “Largest pharmaceuticals by earnings”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=earnings
Underlying data: Yahoo Finance; SEC EDGAR.